Jun 12, 2020 / 11:30AM GMT
Kendra Adams - Agios Pharmaceuticals, Inc. - VP of External Communications & IR
Good morning, everyone. We're going to get started here. I'm going to turn it over to Jackie. For our sell-side friends, if you have not e-mailed myself or Holly and would like to get in the lineup for the Q&A, will you just shoot us an e-mail now and we'll take questions as folks have e-mailed us and then queued up. So with that, Jackie, why don't I turn it over to you? Jackie, we can't hear you just make sure you're unmuted.
Jacqualyn A. Fouse - Agios Pharmaceuticals, Inc. - CEO & Director
Can you hear me?
Kendra Adams - Agios Pharmaceuticals, Inc. - VP of External Communications & IR
Part of it. Thank you. Yes, go ahead.
Jacqualyn A. Fouse - Agios Pharmaceuticals, Inc. - CEO & Director
Everybody. Can I get some thumbs up that you can hear me. Okay. Perfect. Thank you. Good morning, everybody. Why don't I to start off our e virtual investor webcast this morning. So thanks
Agios Pharmaceuticals Inc Virtual Investor Webcast to Review Mitapivat Clinical Data Presented at EHA Annual Congress Transcript
Jun 12, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers